1. Home
  2. TCRT vs IDAI Comparison

TCRT vs IDAI Comparison

Compare TCRT & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRT
  • IDAI
  • Stock Information
  • Founded
  • TCRT 1998
  • IDAI 2016
  • Country
  • TCRT United States
  • IDAI United States
  • Employees
  • TCRT N/A
  • IDAI N/A
  • Industry
  • TCRT Biotechnology: Pharmaceutical Preparations
  • IDAI Computer Software: Prepackaged Software
  • Sector
  • TCRT Health Care
  • IDAI Technology
  • Exchange
  • TCRT Nasdaq
  • IDAI Nasdaq
  • Market Cap
  • TCRT 3.8M
  • IDAI 4.2M
  • IPO Year
  • TCRT N/A
  • IDAI N/A
  • Fundamental
  • Price
  • TCRT $2.08
  • IDAI $0.19
  • Analyst Decision
  • TCRT
  • IDAI
  • Analyst Count
  • TCRT 0
  • IDAI 0
  • Target Price
  • TCRT N/A
  • IDAI N/A
  • AVG Volume (30 Days)
  • TCRT 14.2K
  • IDAI 2.6M
  • Earning Date
  • TCRT 11-14-2024
  • IDAI 11-26-2024
  • Dividend Yield
  • TCRT N/A
  • IDAI N/A
  • EPS Growth
  • TCRT N/A
  • IDAI N/A
  • EPS
  • TCRT N/A
  • IDAI N/A
  • Revenue
  • TCRT $7,000.00
  • IDAI $2,160,186.00
  • Revenue This Year
  • TCRT N/A
  • IDAI N/A
  • Revenue Next Year
  • TCRT N/A
  • IDAI $215.04
  • P/E Ratio
  • TCRT N/A
  • IDAI N/A
  • Revenue Growth
  • TCRT N/A
  • IDAI 69.90
  • 52 Week Low
  • TCRT $1.95
  • IDAI $0.16
  • 52 Week High
  • TCRT $33.00
  • IDAI $2.50
  • Technical
  • Relative Strength Index (RSI)
  • TCRT 44.32
  • IDAI 43.44
  • Support Level
  • TCRT $2.00
  • IDAI $0.16
  • Resistance Level
  • TCRT $2.86
  • IDAI $0.20
  • Average True Range (ATR)
  • TCRT 0.17
  • IDAI 0.03
  • MACD
  • TCRT 0.05
  • IDAI -0.00
  • Stochastic Oscillator
  • TCRT 14.29
  • IDAI 22.48

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility.

Share on Social Networks: